Fig. 4From: Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective studySurvival after recurrence of patients according to the total dose ratio (TDI) of adjuvant chemotherapy (AC). The high-TDI group shows significantly better survival than low-TDI group (median, 20 months vs. 9 months, P = 0.002) and AC(-) group (median, 10 months, vs. high-TDI, P = 0.024)Back to article page